UM

Browse/Search Results:  1-10 of 12 Help

Selected(0)Clear Items/Page:    Sort:
Research and development of anti-Parkinson’s drugs: an analysis from the perspective of technology flows measured by patent citations Journal article
Expert Opinion on Therapeutic Patents, 2019,Volume: 29,Issue: 2,Page: 127-135
Authors:  Qu,Jingwen;  Lu,Jiahong;  Hu,Yuanjia
Favorite |  | TC[WOS]:5 TC[Scopus]:6 | Submit date:2021/03/01
Parkinson’s Disease  Patent Citation Network  Research And Development  Technology Evolution  Technology Flow  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date:2018/10/31
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date:2018/10/30
Alzheimer's disease  patent  technology flow  citation network  research and development  
Research and development of anti-Alzheimer's disease drugs: an update from the perspective of technology flows Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2018,Volume: 28,Issue: 4,Page: 341-350
Authors:  Liu, Kunmeng;  Lin, Hui-Heng;  Pi, Rongbiao;  Mak, Shinghung;  Han, Yifan;  Hu, Yuanjia
Favorite |  | TC[WOS]:7 TC[Scopus]:7 | Submit date:2018/10/30
Alzheimer's disease  patent  technology flow  citation network  research and development  
National innovation system, social entrepreneurship, and rural economic growth in China Journal article
Technological Forecasting & Social Change, 2017,Volume: 121,Page: 238-250
Authors:  Wu, Jie;  Zhuo, Shuaihe;  Wu, Zefu
Favorite |  | TC[WOS]:41 TC[Scopus]:46 | Submit date:2018/10/30
National Innovation System  Social Entrepreneurship  Economic Growth  Research And Development  Rural China  
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码: 135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu;  Rong Shao
Favorite |  | TC[WOS]:0 TC[Scopus]:0 | Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network  
Research and development of anti-Alzheimer’s drugs: an analysis based on technology flows measured by patent citations Journal article
EXPERT OPINION ON THERAPEUTIC PATENTS, 2014,Volume: 24,Issue: 7,Page: 791-800
Authors:  Xu, Jiachen;  Kong, Xiangjun;  Qiu, Lan;  Geng, Xiaomei;  Hu, Yuanjia;  Wang, Yitao
Favorite |  | TC[WOS]:15 TC[Scopus]:16 | Submit date:2018/11/01
Alzheimer's Disease  Patent Citation Network  Research And Development  Technology Cluster  Technology Flow  
Public funding and private investment for R&D: a survey in China’s pharmaceutical industry Journal article
HEALTH RESEARCH POLICY AND SYSTEMS, 2014,Volume: 12,Issue: 27,Page: 27
Authors:  Qiu, Lan;  Chen, Zi-Ya;  Lu, Deng-Yu;  Hu, Hao;  Wang, Yi-Tao
Favorite |  | TC[WOS]:14 TC[Scopus]:13 | Submit date:2018/11/01
Pharmaceutical Industry  Private Investment  Public Funding  Research And Development  
The Antecedents of Corporate Social and Environmental Irresponsibility Journal article
Corporate Social Responsibility and Environmental Management, 2014,Volume: 21,Issue: 5,Page: 286-300
Authors:  Jie Wu
Favorite |  | TC[WOS]:20 TC[Scopus]:20 | Submit date:2019/11/25
Corporate Social And Environmental Irresponsibility  Corporate Social Responsibility  Research And Development  Cost Pressure  Corruption  Emerging Economies  China